Intrinsiqq
Anebulo Pharmaceuticals Inc. logo

Anebulo Pharmaceuticals Inc. Financials

ANEB

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 5 of 6 available years
Income Statement
JUN 2025
~1.3:1 split
JUN 2024
JUN 2023
JUN 2022
~1.7:1 split
JUN 2021
General & Administrative$5$5$6$4$1
Research & Development$4$4$6$3$2
Total Operating Expenses$9$8$12$7$4
Operating Income-$9-$8-$12-$7-$4
Non-Operating
Net Interest Expense-$0-$0––-$0
Other Non-Operating Income (Expense)$1$0$0$0$0
EBT (Earnings Before Tax)––––-$4
Net Income
Net Income-$8-$8-$12-$7-$30
EPS (Basic)-$0.25-$0.32-$0.47$0.29-$2.83
EPS (Diluted)-$0.25-$0.32-$0.47$0.29-$2.22
Weighted Avg Shares (Basic)33.8M25.8M25.1M23.3M13.6M
Weighted Avg Shares (Diluted)33.8M25.8M25.1M23.3M13.6M
Shares Outstanding33.8M25.8M25.1M23.3M13.6M

Anebulo Pharmaceuticals (ANEB) financials: revenue, profit and margins

Anebulo Pharmaceuticals (ANEB) generated about n/a in revenue and -$8 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Anebulo Pharmaceuticals profitable?+

Anebulo Pharmaceuticals reported about -$8 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 6 Feb 2026, covering the period ending 31 Dec 2025, as reported to the SEC. Data last refreshed 26 Sept 2026. How this is calculated.

Fiscal year ends Jun.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ANEB

CompareIntrinsic value
IXHLIncannex Healthcare Inc.
$1.86+6.90%10
INBPIntegrated BioPharma Inc.
$0.16+0.00%13
TERNTerns Pharmaceuticals, Inc.
$0.00+0.00%10
SNNCSibannac Inc.
$0.00+0.00%15
PLPLPlandai Biotechnology Inc.
$0.00+0.00%30
FOLDAmicus Therapeutics, Inc.
No recent price45
DAWNDay One Biopharmaceuticals, Inc.
No recent price10
CELUCelularity Inc.
$0.46-1.88%0

Spot a number that looks wrong? Check it in ANEB's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ANEB

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.